Clinical and Biochemical Profiles according to Homeostasis Model Assessment-insulin Resistance (HOMA-IR) in Korean Women with Polycystic Ovary Syndrome
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
The aim of this study was to investigate the clinical and biochemical profiles according to homeostasis modelassessment of insulin resistance (HOMA-IR) in Korean polycystic ovary syndrome (PCOS) patients. Methods: In 458 PCOS patients diagnosed by the Rotterdam European Society for Human Reproduction and Embryology(ESHRE) criteria, measurements of somatometry, blood test of hormones, glucose metabolic and lipid profiles, and transvaginal ortransrectal ultrasonogram were carried out. HOMA-IR was then calculated and compared with the clinical and biochemical profilesrelated to PCOS. The patients were divided into 4 groups by quartiles of HOMA-IR. Results: The mean level of HOMA-IR was 2.18 ± 1.73. Among the four groups separated according to HOMA-IR, body weight,body mass index (BMI), waist-to-hip ratio (WHR), triglyceride (TG), total cholesterol, high-density lipoprotein (HDL) cholesterol,low-density lipoprotein (LDL) cholesterol, lipid accumulation product (LAP) index, high-sensitivity C-reactive protein (hs-CRP),Apoprotein B, free testosterone, and sex hormone binding globulin (SHBG) were found to be significantly different. TG, LAP index,glucose metabolic profiles, and hs-CRP were positively correlated with HOMA-IR after adjustment for BMI. Conclusion: Our results suggest that the clinical and biochemical profiles which are applicable as cardiovascular risk factors arehighly correlated with HOMA-IR in Korean women with PCOS. (J Menopausal Med 2014;20:104-110)
Abstract
The aim of this study was to investigate the clinical and biochemical profiles according to homeostasis modelassessment of insulin resistance (HOMA-IR) in Korean polycystic ovary syndrome (PCOS) patients. Methods: In 458 PCOS patients diagnosed by the Rotterdam European Society for Human Reproduction and Embryology(ESHRE) criteria, measurements of somatometry, blood test of hormones, glucose metabolic and lipid profiles, and transvaginal ortransrectal ultrasonogram were carried out. HOMA-IR was then calculated and compared with the clinical and biochemical profilesrelated to PCOS. The patients were divided into 4 groups by quartiles of HOMA-IR. Results: The mean level of HOMA-IR was 2.18 ± 1.73. Among the four groups separated according to HOMA-IR, body weight,body mass index (BMI), waist-to-hip ratio (WHR), triglyceride (TG), total cholesterol, high-density lipoprotein (HDL) cholesterol,low-density lipoprotein (LDL) cholesterol, lipid accumulation product (LAP) index, high-sensitivity C-reactive protein (hs-CRP),Apoprotein B, free testosterone, and sex hormone binding globulin (SHBG) were found to be significantly different. TG, LAP index,glucose metabolic profiles, and hs-CRP were positively correlated with HOMA-IR after adjustment for BMI. Conclusion: Our results suggest that the clinical and biochemical profiles which are applicable as cardiovascular risk factors arehighly correlated with HOMA-IR in Korean women with PCOS. (J Menopausal Med 2014;20:104-110)
참고문헌 (21)
- Norman RJ, "Polycystic ovary syndrome", Lancet, 370, pp.685~697 (2007)
- Scicchitano P, "Cardiovascular Risk in Women With PCOS", Endocrinol Metab, 10, pp.611~618 (2012)
- Legro RS, "Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls", Obstet Gynecol Surv, 59, pp.141~154 (2004)
- Nawrocka-Rutkowska J, "Insulin resistance assessment in patients with polycystic ovary syndrome using different diagnostic criteria-impact of metformin treatment", Ann Agric Environ Med, 20, pp.528~532 (2013)
- Wallace TM, "The assessment of insulin resistance in man", Diabet Med, 19, pp.527~534 (2002)
- Rotterdam ESHRE, "ASRM-Sponsored PCOS Consensus Workshop Group", Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, 2004, pp.81, 19~25
- "Waist circumference and waist-hip ratio: report of a WHO expert consultation" (2012)[URL]
- Galluzzo A, "Insulin resistance and polycystic ovary syndrome", Nutr Metab Cardiovasc Dis, 18, pp.511~518 (2008)
- El-Mazny A, "Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome", Gynaecol Obstet, 109, pp.239~241 (2010)
- Diamanti-Kandarakis E, "Pathophysiology and types of dyslipidemia in PCOS", Trends Endocrinol Metab, 18, pp.280~285 (2007)
- Kahn HS, "The“lipid accumulation product”performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison", BMC Cardiovasc Disord, 5, pp.26~ (2005)
- Wiltgen D, "Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome", Hum Reprod, 24, pp.1726~1731 (2009)
- Pesant MH, "Clinically useful predictors of conversion to abnormal glucose tolerance in women with polycystic ovary syndrome", Fertil Steril, 95, pp.210~215 (2011)
- Alebić MS, "Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria", Endocrine, 47, pp.625~630 (2014)
- 한명석, "폐경으로 인한 대사증후군", 대한폐경학회지, 17(3), pp.127~135 (2011), 대한폐경학회[DOI]
- Namkung J, "Comparison of the effects of hormone replacement therapy on bone mineral density, lipid profiles, and biochemical markers of bone metabolism", Korean Soc Menopause, 16, pp.107~115 (2010)
- Welt CK, "Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause", Clin Endocrinol Metab, 98, pp.4629~4638 (2013)
- Carmina E, "Polycystic ovary syndrome: metabolic consequences and long-term management", Clin Lab Invest Suppl, 244, pp.23~26 (2014)
- Carmina E, "A 20-year followup of young women with polycystic ovary syndrome", Obstet Gynecol, 119, pp.263~269 (2012)
- Schmidt J, "Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study", Clin Endocrinol Metab, 96, pp.3794~3803 (2011)
- Shah D, "Polycystic ovaries - beyond menopause", Climacteric, 17, pp.109~115 (2014)